Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients

BACKGROUND: This study investigates the association between exposure to urate-lowering drugs (ULDs) and progression and recovery from chronic kidney disease (CKD). METHODS: We identified 5860 incident gout patients at Chang Gung Memorial Hospital from 2012 to 2015. Propensity score (PS)-weighted Cox...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Ting-Ting, Yu, Kuang-Hui, Kuo, Chang-Fu, Luo, Shue-Fen, Chiou, Meng-Jiun, Lan, Wen-Ching, Chen, Jung-Sheng, Tseng, Wen-Yi, Hsieh, Ao-Ho, Wang, Lian-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751683/
https://www.ncbi.nlm.nih.gov/pubmed/31533805
http://dx.doi.org/10.1186/s13075-019-1993-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751683/
https://www.ncbi.nlm.nih.gov/pubmed/31533805
http://dx.doi.org/10.1186/s13075-019-1993-9

Ejemplares similares